GlaxoSmith intends to open 3 new drug production lines in EgyptVisits : 165

GlaxoSmith intends to open 3 new drug production lines in Egypt

The company plans to open three new production lines in 2019-2020, worth 180 million pounds, the director of GlaxoSmith said.

Amr Mamdouh said in a statement to the Ministry of Investment and International Cooperation, on Sunday, that the companys new investments are distributed as follows: Opening two new production lines for the manufacture of voltaren with investments of 100 million pounds this year.